FOLD

On Thursday, Shares of Amicus Therapeutics (NASDAQ: FOLD) rose 0.53% to $13.22. The stock traded total volume of 397,844 shares lower than the average volume of 3.19M shares. Amicus Therapeutics (FOLD), a global biotechnology company focused on discovering, developing and delivering novel medicines for rare metabolic diseases, recently declared financial […]